Cardiff Oncology (CRDF) PT Lowered to $6 at Piper Sandler
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $1.03 +4.04%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on Cardiff Oncology (NASDAQ: CRDF) to $6.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
- Edison International (EIX) PT Lowered to $63 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
